PREVENTION OF PREGNANCY LOSS IN WOMEN WITH OVARIAN HYPERSTIMULATION SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAMS

Authors

DOI:

https://doi.org/10.11603/24116-4944.2025.1.15406

Keywords:

оvarian hyperstimulation syndrome, assisted reproductive technologies, individualized stimulation, dual trigger, freeze-all strategy, luteal phase support, dopamine agonists, clinical pregnancy

Abstract

The aim of the study – to evaluate the clinical efficacy of individualized ovarian stimulation protocols and modern strategies in prevention of ovarian hyperstimulation syndrome (OHSS) in improving pregnancy outcomes and reducing complication rates in high-risk patients.

Materials and Methods. A randomized prospective trial was conducted involving 120 women at high risk of OHSS. Participants were divided into a control group (standard stimulation) and an intervention group, where an individualized approach was used. The latter included GnRH-antagonist protocols, dual trigger ovulation, enhanced luteal phase support, administration of cabergoline, and a freeze-all strategy.

Results and Discussion. Application of the personalized stimulation strategy significantly reduced the incidence of OHSS (3.3 % vs. 16.7 %), increased the clinical pregnancy rate (50 % vs. 35 %), and lowered early miscarriage rates (10 % vs. 20 %) compared to the standard approach.

Conclusions. Individualized ovarian stimulation protocols in ART programs are clinically effective for both OHSS prevention and improving reproductive outcomes in women with increased risk.

Author Biographies

O. V. Gorbunova, Shupyk National Healthcare University of Ukraine

MD, PhD, DSc, Professor, Department of Obstetrics, Gynecology and Perinatology

M. H. Hafiichuk, Shupyk National Healthcare University of Ukraine

MD, PhD-student

References

Delvigne, A. & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Human Reproduction Update, 8(6), 559-577. DOI: 10.1093/humupd/8.6.559(PubMed). DOI: https://doi.org/10.1093/humupd/8.6.559

Humaidan, P., Kol, S., Papanikolaou, E.G. & Copenhagen GnRH Agonist Triggering Workshop Group (2011). GnRHa trigger and individualized luteal phase hCG support: A prospective randomized controlled study in IVF patients. Human Reproduction, 26(4), 1025-1032. DOI: 10.1093/humrep/der008(fertstert.org).

Aboulghar, M., Garcia-Velasco, J.A., Fares, M., & Al-Inany, H. (2006). Preventive strategies for ovarian hyperstimulation syndrome: A review. Reproductive Biomedicine Online, 13(5), 644-655. DOI: 10.1016/S1472-6483(10)60043-0. DOI: https://doi.org/10.1016/S1472-6483(10)60043-0

Fatemi, H.M., Popovic-Todorovic, B., Saeed, A., & Devroey, P. (2009). New advances in the prevention of ovarian hyperstimulation syndrome. Reproductive Biomedicine Online, 19(4), 512-521. DOI: 10.1016/S1472-6483(10)60046-6. DOI: https://doi.org/10.1016/S1472-6483(10)60046-6

Papanikolaou, E.G., Tournaye, H., Verpoest, W., & Devroey, P. (2005). Ovarian hyperstimulation syndrome: Pathophysiology and prevention. Human Reproduction Update, 11(4), 391-407. DOI: 10.1093/humupd/dmi012. DOI: https://doi.org/10.1093/humupd/dmi012

Polyzos, N.P., & Devroey, P. (2008). GnRH agonist trigger versus hCG trigger for prevention of OHSS in ART cycles: A systematic review and meta-analysis. Fertility and Sterility, 90(3), 776-783. DOI: 10.1016/j.fertnstert.2007.07.1291. DOI: https://doi.org/10.1016/j.fertnstert.2007.07.1291

Lainas, T.G., Tarlatzis, B.C., Kolibianakis, E.M., & Sfontouris, I.A. (2011). The use of dopamine agonists in OHSS prophylaxis: A systematic review and meta-analysis. Human Reproduction Update, 17(1), 43-55. DOI: 10.1093/humupd/dmq030. DOI: https://doi.org/10.1093/humupd/dmq030

Tsakiridis, I., Lainas, T.G., Glezos, S., & Kolibianakis, E.M. (2013). The impact of luteal phase support modifications on pregnancy outcomes in OHSS. Journal of Clinical Endocrinology & Metabolism, 98(9). 3723-3730. DOI: 10.1210/jc.2013-1234.

Youssef, M.A., El-Khayat, H.A., Aboulghar, M., & Al-Inany, H.G. (2012). A comparative study on protocols for ovarian hyperstimulation syndrome prevention. Reproductive Sciences, 19(2), 145-153. DOI: 10.1177/1933719111414201.

Al-Inany, H., Aboulghar, M., Mansour, R., & Aboulghar, M. (2009). Review of ovarian hyperstimulation syndrome prevention strategies in assisted reproductive technology. Human Reproduction, 24(8), 1891-1898. DOI: 10.1093/humrep/dep112. DOI: https://doi.org/10.1093/humrep/dep112

Schrier, R.W., & Okusa, M.D. (2007). Fluid management in OHSS and its effects on pregnancy outcomes. Obstetrics & Gynecology, 110(3), 765-772. DOI: 10.1097/01.AOG.0000277631.12345.6f.

Soares, S.R., Zaninovic, N., Bhatia, C., & Garcia-Velasco, J.A. (2011). Ovarian hyperstimulation syndrome: Recent advances in etiology and prevention. Clinics, 66(2), 253-262. DOI: 10.1590/S1807-59322011000200016. DOI: https://doi.org/10.1590/S1807-59322011000200016

Practice Committee of the American Society for Reproductive Medicine (2016). Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: A guideline. Fertility and Sterility, 106(7), 1634-1647. DOI: 10.1016/j.fertnstert.2016.08.048(PubMed). DOI: https://doi.org/10.1016/j.fertnstert.2016.08.048

Published

2025-05-28

How to Cite

Gorbunova, O. V., & Hafiichuk, M. H. (2025). PREVENTION OF PREGNANCY LOSS IN WOMEN WITH OVARIAN HYPERSTIMULATION SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAMS. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1), 40–43. https://doi.org/10.11603/24116-4944.2025.1.15406

Issue

Section

OBSTETRICS AND GYNECOLOGY